NASDAQ:LFST LifeStance Health Group (LFST) Stock Forecast, Price & News $8.46 -0.09 (-1.05%) (As of 06/7/2023 ET) Add Compare Share Share Today's Range$8.44▼$8.7350-Day Range$7.19▼$8.5552-Week Range$4.22▼$10.50Volume1.04 million shsAverage Volume591,634 shsMarket Capitalization$3.19 billionP/E RatioN/ADividend YieldN/APrice Target$8.04 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media LifeStance Health Group MarketRank™ ForecastAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside4.9% Downside$8.04 Price TargetShort InterestBearish9.08% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$1.74 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.29) to ($0.23) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.18 out of 5 starsMedical Sector952nd out of 981 stocksHealth Services Industry13th out of 13 stocks 1.3 Analyst's Opinion Consensus RatingLifeStance Health Group has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.04, LifeStance Health Group has a forecasted downside of 4.9% from its current price of $8.46.Amount of Analyst CoverageLifeStance Health Group has only been the subject of 1 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted9.08% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 12.4, which indicates bearish sentiment.Change versus previous monthShort interest in LifeStance Health Group has recently increased by 4.70%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LFST. Previous Next 2.8 News and Social Media Coverage News SentimentLifeStance Health Group has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for LifeStance Health Group this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for LFST on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows1 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,744,368.00 in company stock.Percentage Held by InsidersOnly 8.50% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions76.49% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for LifeStance Health Group are expected to grow in the coming year, from ($0.29) to ($0.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is -16.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is -16.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 2.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About LifeStance Health Group (NASDAQ:LFST) StockLifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform, as well as offers patients care virtually through its online delivery platform or in-person at its centers in 33 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.Read More Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address LFST Stock News HeadlinesMay 24, 2023 | finance.yahoo.comLifeStance to Present at the 44th Annual Goldman Sachs Healthcare ConferenceMay 20, 2023 | msn.comGoldman Sachs Maintains LifeStance Health Group (LFST) Neutral RecommendationJune 7, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.May 19, 2023 | markets.businessinsider.comGoldman Sachs Remains a Hold on Lifestance Health Group (LFST)May 17, 2023 | morningstar.comLifeStance Health Group Inc Ordinary SharesMay 17, 2023 | americanbankingnews.comLifeStance Health Group (NASDAQ:LFST) Shares Gap Down to $8.54May 16, 2023 | finance.yahoo.comLifeStance Health Group, Inc. (NASDAQ:LFST) Q1 2023 Earnings Call TranscriptMay 15, 2023 | americanbankingnews.comTD Cowen Lowers LifeStance Health Group (NASDAQ:LFST) to Market PerformJune 7, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.May 15, 2023 | americanbankingnews.comLifeStance Health Group, Inc. (NASDAQ:LFST) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 15, 2023 | seekingalpha.comLifeStance Health Group, Inc. 2023 Q1 - Results - Earnings Call PresentationMay 12, 2023 | msn.comMorgan Stanley Maintains LifeStance Health Group (LFST) Overweight RecommendationMay 11, 2023 | finance.yahoo.comGennev and LifeStance Health Partner to Provide Integrated Care for Women in MenopauseMay 11, 2023 | finance.yahoo.comQ1 2023 Lifestance Health Group Inc Earnings CallMay 10, 2023 | finance.yahoo.comLifeStance Health Group (LFST) Reports Q1 Loss, Tops Revenue EstimatesMay 10, 2023 | finanznachrichten.deLifeStance Health Group, Inc.: LifeStance Reports First Quarter 2023 ResultsMay 10, 2023 | finance.yahoo.comLifeStance Reports First Quarter 2023 ResultsMay 9, 2023 | markets.businessinsider.comHere's what Wall Street expects from LifeStance Health Group's earnings reportMay 9, 2023 | americanbankingnews.comLifeStance Health Group (LFST) Scheduled to Post Earnings on WednesdayMay 1, 2023 | americanbankingnews.comLifeStance Health Group, Inc. (NASDAQ:LFST) Sees Large Growth in Short InterestApril 20, 2023 | marketwatch.comSHAREHOLDER ALERT: Morris Kandinov Investigating LFST, BRY, CDNA, and OPEN; Shareholders are Encouraged to Contact the FirmApril 19, 2023 | finance.yahoo.comLifeStance to Host First Quarter 2023 Earnings Conference Call on May 10, 2023April 7, 2023 | americanbankingnews.comLifeStance Health Group, Inc. (NASDAQ:LFST) Insider Sells $722,686.38 in StockApril 6, 2023 | seekingalpha.comLifeStance Health Group's Position In The Booming Mental Health MarketApril 3, 2023 | americanbankingnews.comLifeStance Health Group, Inc. (NASDAQ:LFST) Sees Large Decrease in Short InterestMarch 31, 2023 | finance.yahoo.comCalculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)March 28, 2023 | markets.businessinsider.comMorgan Stanley Keeps Their Buy Rating on Lifestance Health Group (LFST)See More Headlines LFST Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LFST Company Calendar Last Earnings5/10/2023Today6/07/2023Next Earnings (Estimated)8/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Health services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:LFST CUSIPN/A CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees7,830Year FoundedN/APrice Target and Rating Average Stock Price Forecast$8.04 High Stock Price Forecast$9.00 Low Stock Price Forecast$7.25 Forecasted Upside/Downside-5.6%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-215,560,000.00 Net Margins-20.63% Pretax Margin-22.22% Return on Equity-12.32% Return on Assets-9.06% Debt Debt-to-Equity Ratio0.15 Current Ratio1.17 Quick Ratio1.17 Sales & Book Value Annual Sales$859.54 million Price / Sales3.73 Cash FlowN/A Price / Cash FlowN/A Book Value$4.04 per share Price / Book2.11Miscellaneous Outstanding Shares376,770,000Free Float344,740,000Market Cap$3.21 billion OptionableNot Optionable Beta0.88 Key ExecutivesMr. Kenneth Alan Burdick (Age 64)CEO & Chairman Comp: $624.22kMr. Danish J. Qureshi (Age 38)Pres & COO Comp: $342.2kMr. David Patrick Bourdon (Age 53)Chief Financial Officer & Treasurer Comp: $368.6kMs. Monica ProkockiVP of Investor RelationsMr. Ryan Pardo (Age 47)Chief Legal Officer & Sec. Brooke MatthewsDirector of PRMs. Ann Varanakis (Age 45)Chief People Officer Mr. Pablo Pantaleoni (Age 35)Chief Digital Officer Mr. Kevin Michael Mullins (Age 38)Chief Devel. Officer Dr. Anisha Patel-Dunn D.O. (Age 47)Chief Medical Officer More ExecutivesKey CompetitorsSage TherapeuticsNASDAQ:SAGEKrystal BiotechNASDAQ:KRYSAxsome TherapeuticsNASDAQ:AXSMZai LabNASDAQ:ZLABiRhythm TechnologiesNASDAQ:IRTCView All CompetitorsInsiders & InstitutionsJPMorgan Chase & Co.Bought 22,367 shares on 5/18/2023Ownership: 0.029%New York State Common Retirement FundSold 16,500 shares on 5/18/2023Ownership: 0.009%Squarepoint Ops LLCBought 30,501 shares on 5/16/2023Ownership: 0.011%Jane Street Group LLCBought 25,360 shares on 5/16/2023Ownership: 0.007%Balyasny Asset Management L.P.Bought 11,362 shares on 5/16/2023Ownership: 0.003%View All Insider TransactionsView All Institutional Transactions LFST Stock - Frequently Asked Questions Should I buy or sell LifeStance Health Group stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifeStance Health Group in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LFST shares. View LFST analyst ratings or view top-rated stocks. What is LifeStance Health Group's stock price forecast for 2023? 6 brokers have issued 1-year price targets for LifeStance Health Group's shares. Their LFST share price forecasts range from $7.25 to $9.00. On average, they expect the company's stock price to reach $8.04 in the next twelve months. This suggests that the stock has a possible downside of 5.6%. View analysts price targets for LFST or view top-rated stocks among Wall Street analysts. How have LFST shares performed in 2023? LifeStance Health Group's stock was trading at $4.94 at the beginning of 2023. Since then, LFST stock has increased by 72.5% and is now trading at $8.52. View the best growth stocks for 2023 here. When is LifeStance Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023. View our LFST earnings forecast. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) announced its earnings results on Wednesday, May, 10th. The company reported ($0.09) earnings per share for the quarter, topping analysts' consensus estimates of ($0.11) by $0.02. The company earned $252.59 million during the quarter, compared to the consensus estimate of $246.04 million. LifeStance Health Group had a negative net margin of 20.63% and a negative trailing twelve-month return on equity of 12.32%. What ETFs hold LifeStance Health Group's stock? ETFs with the largest weight of LifeStance Health Group (NASDAQ:LFST) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), SPDR S&P Health Care Services ETF (XHS), First Trust Small Cap Growth AlphaDEX Fund (FYC), iShares U.S. Healthcare Providers ETF (IHF).Fidelity New Millennium ETF (FMIL), What guidance has LifeStance Health Group issued on next quarter's earnings? LifeStance Health Group issued an update on its second quarter 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $250.00 million-$260.00 million, compared to the consensus revenue estimate of $250.46 million. When did LifeStance Health Group IPO? (LFST) raised $640 million in an initial public offering on Thursday, June 10th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. What is LifeStance Health Group's stock symbol? LifeStance Health Group trades on the NASDAQ under the ticker symbol "LFST." Who are LifeStance Health Group's major shareholders? LifeStance Health Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include FMR LLC (6.85%), BlackRock Inc. (1.38%), Principal Financial Group Inc. (0.98%), Geode Capital Management LLC (0.49%), State Street Corp (0.39%) and O Brien Wealth Partners LLC (0.22%). Insiders that own company stock include Anisha Patel-Dunn, Gwen H Booth, Jeffrey Crisan, Jesse Michael Bruff, Kenneth T Mills, Kevin Michael Mullins, Michael K Lester, Silversmith Partners I Gp, Llc, Summit Partners Growth Equity and Warren Gouk. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is LifeStance Health Group's stock price today? One share of LFST stock can currently be purchased for approximately $8.52. How much money does LifeStance Health Group make? LifeStance Health Group (NASDAQ:LFST) has a market capitalization of $3.21 billion and generates $859.54 million in revenue each year. The company earns $-215,560,000.00 in net income (profit) each year or ($0.52) on an earnings per share basis. How many employees does LifeStance Health Group have? The company employs 7,830 workers across the globe. How can I contact LifeStance Health Group? The official website for the company is www.lifestance.com. The company can be reached via phone at 602-767-2100. This page (NASDAQ:LFST) was last updated on 6/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.